NCT00160550View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

PHASE3CompletedINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Generalized Convulsive Epilepsy
Interventions
DRUG

Levetiracetam

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY